Article
Myeloma Is Not a Single Disease.
Journal of oncology practice - 1 Apr 2016
Lonial Sagar, Nooka Ajay K
Abstract excerpt
Treatment of plasma cell disorders has dramatically improved during the past decade as a result of the availability of new biology-based drugs, such as proteasome inhibitors and immunomodulatory agents. With increased attention to disease biology, however, it has become clear that there are many different subsets of patients with myeloma with different biologic drivers as well as different patient-based...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
